2,289 research outputs found
Generalized Gravi-Electromagnetism
A self consistant and manifestly covariant theory for the dynamics of four
charges (masses) (namely electric, magnetic, gravitational, Heavisidian) has
been developed in simple, compact and consistent manner. Starting with an
invariant Lagrangian density and its quaternionic representation, we have
obtained the consistent field equation for the dynamics of four charges. It has
been shown that the present reformulation reproduces the dynamics of individual
charges (masses) in the absence of other charge (masses) as well as the
generalized theory of dyons (gravito - dyons) in the absence gravito - dyons
(dyons). key words: dyons, gravito - dyons, quaternion PACS NO: 14.80H
Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression
Low pH in the tumor micromilieu is a recognized pathological feature of cancer. This attribute of cancerous cells has been targeted herein for the controlled release of chemotherapeutics at the tumour site, while sparing healthy tissues. To this end, pH-sensitive, hollow ZnO-nanocarriers loaded with paclitaxel were synthesized and their efficacy studied in breast cancer in vitro and in vivo. The nanocarriers were surface functionalized with folate using click-chemistry to improve targeted uptake by the malignant cells that over-express folate-receptors. The nanocarriers released ~75% of the paclitaxel payload within six hours in acidic pH, which was accompanied by switching of fluorescence from blue to green and a 10-fold increase in the fluorescence intensity. The fluorescence-switching phenomenon is due to structural collapse of the nanocarriers in the endolysosome. Energy dispersion X-ray mapping and whole animal fluorescent imaging studies were carried out to show that combined pH and folate-receptor targeting reduces off-target accumulation of the nanocarriers. Further, a dual cell-specific and pH-sensitive nanocarrier greatly improved the efficacy of paclitaxel to regress subcutaneous tumors in vivo. These nanocarriers could improve chemotherapy tolerance and increase anti-tumor efficacy, while also providing a novel diagnostic read-out through fluorescent switching that is proportional to drug release in malignant tissues
Full potential LAPW calculation of electron momentum density and related properties of Li
Electron momentum density and Compton profiles in Lithium along , and directions are calculated using Full-Potential Linear
Augmented Plane Wave basis within generalized gradient approximation. The
profiles have been corrected for correlations with Lam-Platzman formulation
using self-consistent charge density. The first and second derivatives of
Compton profiles are studied to investigate the Fermi surface breaks. Decent
agreement is observed between recent experimental and our calculated values.
Our values for the derivatives are found to be in better agreement with
experiments than earlier theoretical results. Two-photon momentum density and
one- and two-dimensional angular correlation of positron annihilation radiation
are also calculated within the same formalism and including the
electron-positron enhancement factor.Comment: 11 pages, 7 figures TO appear in Physical Review
Multifractal stationary random measures and multifractal random walks with log-infinitely divisible scaling laws
We define a large class of continuous time multifractal random measures and
processes with arbitrary log-infinitely divisible exact or asymptotic scaling
law. These processes generalize within a unified framework both the recently
defined log-normal Multifractal Random Walk (MRW) [Bacry-Delour-Muzy] and the
log-Poisson "product of cynlindrical pulses" [Barral-Mandelbrot]. Our
construction is based on some ``continuous stochastic multiplication'' from
coarse to fine scales that can be seen as a continuous interpolation of
discrete multiplicative cascades. We prove the stochastic convergence of the
defined processes and study their main statistical properties. The question of
genericity (universality) of limit multifractal processes is addressed within
this new framework. We finally provide some methods for numerical simulations
and discuss some specific examples.Comment: 24 pages, 4 figure
A Fuzzy Inference System for Closed-Loop Deep Brain Stimulation in Parkinson’s Disease
Parkinsons disease is a complex neurodegenerative disorder for which patients present many symptoms, tremor being the main one. In advanced stages of the disease, Deep Brain Stimulation is a generalized therapy which can significantly improve the motor symptoms. However despite its beneficial effects on treating the symptomatology, the technique can be improved. One of its main limitations is that the parameters are fixed, and the stimulation is provided uninterruptedly, not taking into account any fluctuation in the patients state. A closed-loop system which provides stimulation by demand would adjust the stimulation to the variations in the state of the patient, stimulating only when it is necessary. It would not only perform a more intelligent stimulation, capable of adapting to the changes in real time, but also extending the devices battery life, thereby avoiding surgical interventions. In this work we design a tool that learns to recognize the principal symptom of Parkinsons disease and particularly the tremor. The goal of the designed system is to detect the moments the patient is suffering from a tremor episode and consequently to decide whether stimulation is needed or not. For that, local field potentials were recorded in the subthalamic nucleus of ten Parkinsonian patients, who were diagnosed with tremor-dominant Parkinsons disease and who underwent surgery for the implantation of a neurostimulator. Electromyographic activity in the forearm was simultaneously recorded, and the relation between both signals was evaluated using two different synchronization measures. The results of evaluating the synchronization indexes on each moment represent the inputs to the designed system. Finally, a fuzzy inference system was applied with the goal of identifying tremor episodes. Results are favourable, reaching accuracies of higher 98.7 % in 70 % of the patients.Centro de Investigación Biomédica en RedDepto. de Psicología Experimental, Procesos Cognitivos y LogopediaDepto. de Radiología, Rehabilitación y FisioterapiaFac. de PsicologíaFac. de MedicinaTRUEpu
Three-dimensional analysis of the proximal humeral and glenoid geometry using MicroScribe 3D digitizer
Purpose: To understand the geometry of the proximal humerus and glenoid fossa to facilitate the design of components used in shoulder arthroplasty. The aim is to evaluate the geometry of the proximal humerus and glenoid fossa and their relationship using a MicroScribe 3D digitizer.Methods: Scans and measurements were obtained from 20 pairs of dry proximal humeri and scapulae [10 female and 10 male cadavers: median age 81 years (range 70-94 years)] using a MicroScribe 3D digitizer and Rhinoceros software.Results: Means (±SD) of humeral inclination, medial wall angle of the bicipital groove, and radius of the humeral head values were 135 ± 11°, 39 ± 19°, and 14 ± 3 mm, respectively. Means (±SD) of glenoid height and width were 35 ± 4 and 26 ± 4 mm, while the means (±SD) of the angles of glenoid inclination, retroversion, and rotation were 87 ± 32°, 96 ± 10°, and 9 ± 6°, respectively. A significant difference in glenoid height (P ≤ 0.002) and width (P ≤ 0.0001) was observed between males and females, despite them having almost an identical radius of the humeral head, glenoid inclination, retroversion, and angle of rotation. There was also a significant difference (P ≤ 0.01) in the angle of glenoid retroversion between the right and left sides.Conclusions: Using a MicroScribe 3D digitizer, the glenoid fossa was observed to be significantly smaller in females than males; furthermore, there was a difference in glenoid retroversion between the right and left sides.</p
Essential oil composition of petiole of Cinnamomum verum Bercht. & Presl.
Essential oil isolated from the petiole of Cinnamomum verum was analysed by gaschromatography and gas chromatography-mass spectrometry. Twenty five compoundsaccounting for 87.31% of the total essential oil were identified. (E)-Cinnamaldehyde (33.04%)followed by eugenol (17.32%), linalool (16.85%) and (E)-cinnamyl acetate (11.78%) were themain components of the essential oil. This is the first report on the composition of essentialoil of petiole of C. verum.
 
Measurement of an excess in the yield of J/ at very low in Pb-Pb collisions at = 2.76 TeV
We report on the first measurement of an excess in the yield of J/ at
very low transverse momentum ( GeV/) in peripheral hadronic
Pb-Pb collisions at = 2.76 TeV, performed by ALICE at the
CERN LHC. Remarkably, the measured nuclear modification factor of J/ in
the rapidity range reaches about 7 (2) in the range 0-0.3
GeV/ in the 70-90% (50-70%) centrality class. The J/ production cross
section associated with the observed excess is obtained under the hypothesis
that coherent photoproduction of J/ is the underlying physics mechanism.
If confirmed, the observation of J/ coherent photoproduction in Pb-Pb
collisions at impact parameters smaller than twice the nuclear radius opens new
theoretical and experimental challenges and opportunities. In particular,
coherent photoproduction accompanying hadronic collisions may provide insight
into the dynamics of photoproduction and nuclear reactions, as well as become a
novel probe of the Quark-Gluon Plasma.Comment: 18 pages, 3 captioned figures, 1 table, authors from page 13,
published version, figures at
http://aliceinfo.cern.ch/ArtSubmission/node/191
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial
IMPORTANCE: Secretory phospholipase A2(sPLA2) generates bioactive phospholipid products implicated in atherosclerosis. The sPLA2inhibitor varespladib has favorable effects on lipid and inflammatory markers; however, its effect on cardiovascular outcomes is unknown. OBJECTIVE: To determine the effects of sPLA2inhibition with varespladib on cardiovascular outcomes. DESIGN, SETTING, AND PARTICIPANTS: A double-blind, randomized, multicenter trial at 362 academic and community hospitals in Europe, Australia, New Zealand, India, and North America of 5145 patients randomized within 96 hours of presentation of an acute coronary syndrome (ACS) to either varespladib (n = 2572) or placebo (n = 2573) with enrollment between June 1, 2010, and March 7, 2012 (study termination on March 9, 2012). INTERVENTIONS: Participants were randomized to receive varespladib (500 mg) or placebo daily for 16 weeks, in addition to atorvastatin and other established therapies. MAIN OUTCOMES AND MEASURES: The primary efficacy measurewas a composite of cardiovascular mortality, nonfatal myocardial infarction (MI), nonfatal stroke, or unstable angina with evidence of ischemia requiring hospitalization at 16 weeks. Six-month survival status was also evaluated. RESULTS: At a prespecified interim analysis, including 212 primary end point events, the independent data and safety monitoring board recommended termination of the trial for futility and possible harm. The primary end point occurred in 136 patients (6.1%) treated with varespladib compared with 109 patients (5.1%) treated with placebo (hazard ratio [HR], 1.25; 95%CI, 0.97-1.61; log-rank P = .08). Varespladib was associated with a greater risk of MI (78 [3.4%] vs 47 [2.2%]; HR, 1.66; 95%CI, 1.16-2.39; log-rank P = .005). The composite secondary end point of cardiovascular mortality, MI, and stroke was observed in 107 patients (4.6%) in the varespladib group and 79 patients (3.8%) in the placebo group (HR, 1.36; 95% CI, 1.02-1.82; P = .04). CONCLUSIONS AND RELEVANCE: In patients with recent ACS, varespladib did not reduce the risk of recurrent cardiovascular events and significantly increased the risk of MI. The sPLA2inhibition with varespladib may be harmful and is not a useful strategy to reduce adverse cardiovascular outcomes after ACS. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01130246. Copyright 2014 American Medical Association. All rights reserved
The completion of the Mammalian Gene Collection (MGC)
Since its start, the Mammalian Gene Collection (MGC) has sought to provide at least one full-protein-coding sequence cDNA clone for every human and mouse gene with a RefSeq transcript, and at least 6200 rat genes. The MGC cloning effort initially relied on random expressed sequence tag screening of cDNA libraries. Here, we summarize our recent progress using directed RT-PCR cloning and DNA synthesis. The MGC now contains clones with the entire protein-coding sequence for 92% of human and 89% of mouse genes with curated RefSeq (NM-accession) transcripts, and for 97% of human and 96% of mouse genes with curated RefSeq transcripts that have one or more PubMed publications, in addition to clones for more than 6300 rat genes. These high-quality MGC clones and their sequences are accessible without restriction to researchers worldwide
- …
